Lyn W Freeman1, Rebecca White2, Chelsea G Ratcliff3, Sue Sutton1, Mary Stewart4, J Lynn Palmer5, Judith Link6, Lorenzo Cohen7. 1. Mind Matters Research LLC, 7926 Port Orford Dr., Anchorage, AK, 99507, USA. 2. Arctic Skye Family Medicine, 561 S Denali Suite E, Palmer, AK, 99645, USA. 3. Department of Psychology, University of Houston, 126 Heyne Building, Houston, TX, 77204, USA. 4. Alaska Oncology and Hematology LLC, 2925 DeBarr Road, Suite 300, Anchorage, AK, 99508, USA. 5. Department of Biostatistics, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA. 6. Cancer Center Program, Alaska Regional Hospital, 2801 DeBarr Rd, Anchorage, AK, 99508, USA. 7. Department of General Oncology and the Integrative Medicine Department, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX, 77030, USA.
Abstract
OBJECTIVE: This multi-site randomized trial evaluates the quality of life (QOL) benefits of an imagery-based group intervention titled 'Envision the Rhythms of Life'(ERL). METHODS:Breast cancer survivors >6 weeks post-treatment were randomized to attend five weekly 4-h group sessions at a community center with therapist present (live delivery (LD), n = 48), therapist streamed via telemedicine (telemedicine delivery (TD), n = 23), or to a waitlist control (WL) group (n = 47). Weekly individual phone calls to encourage at-home practice began at session one and continued until the 3-month follow-up. Seven self-report measures of QOL were examined at baseline, 1-month and 3-month post-treatments including health-related and breast cancer-specific QOL, fatigue, cognitive function, spirituality, distress, and sleep. RESULTS: The Bonferroni method was used to correct for multiple comparisons, and alpha was adjusted to 0.01. Linear multilevel modeling analyses revealed less fatigue, cognitive dysfunction, and sleep disturbance for LD and TD compared with WL across the follow-up (p's < 0.01). Changes in fatigue, cognitive dysfunction, sleep disturbance, and health-related and breast cancer-related QOL were clinically significant. There were no differences between LD and TD. CONCLUSIONS: Both the live and telemedicine delivered ERL intervention resulted in improvements in multiple QOL domains for breast cancer survivors compared with WL. Further, there were no significant differences between LD and TD, suggesting telemedicine delivered ERL intervention may represent an effective and viable option for cancer survivors in remote areas.
RCT Entities:
OBJECTIVE: This multi-site randomized trial evaluates the quality of life (QOL) benefits of an imagery-based group intervention titled 'Envision the Rhythms of Life'(ERL). METHODS:Breast cancer survivors >6 weeks post-treatment were randomized to attend five weekly 4-h group sessions at a community center with therapist present (live delivery (LD), n = 48), therapist streamed via telemedicine (telemedicine delivery (TD), n = 23), or to a waitlist control (WL) group (n = 47). Weekly individual phone calls to encourage at-home practice began at session one and continued until the 3-month follow-up. Seven self-report measures of QOL were examined at baseline, 1-month and 3-month post-treatments including health-related and breast cancer-specific QOL, fatigue, cognitive function, spirituality, distress, and sleep. RESULTS: The Bonferroni method was used to correct for multiple comparisons, and alpha was adjusted to 0.01. Linear multilevel modeling analyses revealed less fatigue, cognitive dysfunction, and sleep disturbance for LD and TD compared with WL across the follow-up (p's < 0.01). Changes in fatigue, cognitive dysfunction, sleep disturbance, and health-related and breast cancer-related QOL were clinically significant. There were no differences between LD and TD. CONCLUSIONS: Both the live and telemedicine delivered ERL intervention resulted in improvements in multiple QOL domains for breast cancer survivors compared with WL. Further, there were no significant differences between LD and TD, suggesting telemedicine delivered ERL intervention may represent an effective and viable option for cancer survivors in remote areas.
Authors: Jeff A Sloan; Marlene H Frost; Rick Berzon; Amylou Dueck; Gordon Guyatt; Carol Moinpour; Mirjam Sprangers; Carol Ferrans; David Cella Journal: Support Care Cancer Date: 2006-06-23 Impact factor: 3.603
Authors: Janice K Kiecolt-Glaser; Jennifer E Graham; William B Malarkey; Kyle Porter; Stanley Lemeshow; Ronald Glaser Journal: Psychoneuroendocrinology Date: 2008-04 Impact factor: 4.905
Authors: Cecile A Lengacher; Richard R Reich; Carly L Paterson; Heather S Jim; Sophia Ramesar; Carissa B Alinat; Pinky H Budhrani; Jerrica R Farias; Melissa M Shelton; Manolete S Moscoso; Jong Y Park; Kevin E Kip Journal: Psychooncology Date: 2014-06-18 Impact factor: 3.894
Authors: Rebecca A Campo; Karen Bluth; Sheila J Santacroce; Sarah Knapik; Julia Tan; Stuart Gold; Kamaira Philips; Susan Gaylord; Gary N Asher Journal: Support Care Cancer Date: 2017-01-19 Impact factor: 3.603
Authors: Samantha J Mayo; Maryam Lustberg; Haryana M Dhillon; Zev M Nakamura; Deborah H Allen; Diane Von Ah; Michelle C Janelsins; Alexandre Chan; Karin Olson; Chia Jie Tan; Yi Long Toh; Jeong Oh; Lisa Grech; Yin Ting Cheung; Ishwaria Mohan Subbiah; Duska Petranovic; James D'Olimpio; Margherita Gobbo; Susanne Koeppen; Charles L Loprinzi; Linda Pang; Shivani Shinde; Olanipekun Ntukidem; Katherine B Peters Journal: Support Care Cancer Date: 2020-11-24 Impact factor: 3.603
Authors: Laurie E McLouth; C Graham Ford; James E Pustejovsky; Crystal L Park; Allen C Sherman; Kelly Trevino; John M Salsman Journal: Psychooncology Date: 2020-10-12 Impact factor: 3.894
Authors: Anna C Singleton; Rebecca Raeside; Karice K Hyun; Stephanie R Partridge; Gian Luca Di Tanna; Nashid Hafiz; Qiang Tu; Justin Tat-Ko; Stephanie Che Mun Sum; Kerry A Sherman; Elisabeth Elder; Julie Redfern Journal: J Clin Oncol Date: 2022-05-02 Impact factor: 50.717
Authors: Charlene J Treanor; Una C McMenamin; Roisin F O'Neill; Chris R Cardwell; Mike J Clarke; Marie Cantwell; Michael Donnelly Journal: Cochrane Database Syst Rev Date: 2016-08-16
Authors: Karen M Goldstein; Leah L Zullig; Eric A Dedert; Amir Alishahi Tabriz; Timothy W Brearly; Giselle Raitz; Suchita Shah Sata; John D Whited; Hayden B Bosworth; Adelaide M Gordon; Avishek Nagi; John W Williams; Jennifer M Gierisch Journal: J Gen Intern Med Date: 2018-10-03 Impact factor: 6.473